Moreover, whereas mutations in SDH and FH occur throughout the gene, the majority of IDH mutations identified in gliomas and AML are changes in the amino acid residues R132 in IDH1 and either R172 or R140 in IDH2 [31]. This evidence concerns the gene IDH2 and acute myeloid leukemia.